Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Abstract: A system clock reference is transmitted to user devices over a short range communication channel and used to calculated a clock offset. The clock offset is stored together with a user identifier in a server memory, from which the clock offset can be retrieved when receiving the user identifier together with a video stream of video frames tagged with respective timestamps. The timestamps are converted into capture times according to a system clock using the retrieved clock offsets. Video streams from multiple user devices thereby have video frames timestamped using a same clock reference and can be time aligned.

Abstract: Embodiments of systems and methods for measuring a geometric attribute of a hole structure in a semiconductor chip are disclosed. In an example, an optical spectrum signal corresponding to the hole structure in the semiconductor chip is received. The optical spectrum signal is characterized by one or more optical features. The geometric attribute of the hole structure is determined based, at least in part, on the optical features using a model. The model is trained from a plurality of training samples each including a pair of an optical spectrum signal and a labeled reference signal both corresponding to a same hole structure.

Abstract: Provided are an organic electroluminescent material and a device comprising the same. The organic electroluminescent material is a novel compound having a parent core structure formed by fusing indole and pyrrole with an azamacrocycle and bonded with benzoquinazoline or benzoquinoxaline and similar structures thereof. The organic electroluminescent material may be used as a host material in an electroluminescent device. The novel compound can provide better device performance in the electroluminescent device. Further provided are an electroluminescent device and a compound formulation.

Abstract: Devices for mitigating or stopping noise or surface current on a display are provided. An electronic device including a display may include a display substrate, a mid-support plate that is adjacent to the display substrate, and a lower support plate that is adjacent to the mid-support plate. A space exists between the mid-support plate and the lower support plate. The mid-support plate includes one or more electromagnetic band gap (EBG) structures formed through the mid-support plate, one or more electromagnetic band gap structures mounted onto the mid-support plate, or both. The one or more electromagnetic band gap structures may mitigate or stop surface current flow across the display.

Abstract: A modular valve system includes a modular valve body having an inlet, an outlet, a through-hole, and a fluid flow path between the inlet and the outlet. The modular valve body is used to assemble any one of a pressure regulating valve, a slam-shut valve, or a flow control valve, and the through-hole is configured to receive a component of any one of the pressure regulating valve, the slam-shut valve, and the flow control valve.

Abstract: A system clock reference is transmitted to user devices (1, 2, 3) over a short range communication channel (40) and used to calculated a clock offset. The clock offset is stored together with a user identifier in a server memory (15), from which the clock offset can be retrieved when receiving the user identifier together with a video stream (21, 22, 23) of video frames (31, 32, 33) tagged with respective timestamps. The timestamps are converted into capture times according to a system clock (17) using the retrieved clock offsets. Video streams (21, 22, 23) from multiple user devices (1, 2, 3) thereby have video frames timestamped using a same clock reference and can be time aligned.

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R6, Y1, Y2, Y3, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, Y, L1, G1, X1, X2, L2, R2, R3, and R4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R6, Y1, Y2, Y3, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).

Abstract: An organic electroluminescent material and a device thereof are disclosed. The organic electroluminescent material uses a compound having a novel carbazole structure, and can be used as hole blocking material, host material in an electroluminescent device. These novel compounds can provide better device performance, such as obtaining device performance of very low driving-voltage, high efficiency, and long lifetime.

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Abstract: The present application provides a load balancing system. In an example, the load balancing system includes a client, a first load balancer coupled to the client, a plurality of security forwarding devices whose load sides are coupled to the first load balancer and forwarding sides are coupled to a second load balancer, the second load balancer, and a server coupled with the second load balancer. In the load balancing system, service traffic resources can be accurately allocated to the target security forwarding device selected by the scheduling algorithm, so as to balance load.

Abstract: A method and device for displaying reference content, and a storage medium thereof are provided. In some embodiments, the method includes displaying a first interface in response to an operation of enabling the first interface; displaying multiple second interfaces on the first interface in a form of floating window in response to an operation of enabling reference content, the multiple second interfaces including different reference content respectively; and displaying, in response to an operation of selecting a second interface from the multiple second interfaces, the selected second interface on the first interface in an overlaying manner. The formation arranging efficiency and communication efficiency between game players and the reference content can be improved by the above technical solution.

Abstract: The disclosure relates to a method and device for displaying a floating window. The method includes monitoring an amount of floating windows that are created on a desktop for respective ones of a plurality of applications; determining that there is more than one of the plurality of applications for which a floating window is created on the desktop; forbidding permissions of multiple floating windows based on the determination; launching a system floating window; hiding and containing the multiple floating windows in the system floating window; receiving an activating instruction for the system floating window; extending and displaying the multiple floating windows contained in the system floating window; receiving a selection instruction for the multiple floating windows; displaying a selected floating window of the multiple floating windows; allowing a permission of the selected floating window; and masking a permission of the system floating window.

Abstract: A method for displaying an application interface on a terminal. The method includes determining a first application of an application group. The application group includes multiple identical applications installed on the terminal, and the first application is a most recently used application of the multiple identical applications. The method further includes displaying application indication information in a specific area in an interface of the terminal, for indicating the first application.

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).